Fanconi anemia is a highly penetrant cancer susceptibility syndrome.
Dokal
Inderjeet
I
Academic Unit of Paediatrics, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, England. i.dokal@qmul.ac.uk
D001855:Bone Marrow Diseases / Q000453:epidemiology / Q000235:genetics; D019457:Chromosome Breakage; D015331:Cohort Studies; D004249:DNA Damage; D004260:DNA Repair / Q000235:genetics*; D018450:Disease Progression; D005199:Fanconi Anemia / Q000235:genetics* / Q000601:surgery; D051856:Fanconi Anemia Complementation Group Proteins / Q000235:genetics* / Q000502:physiology; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000453:epidemiology / Q000235:genetics; D009369:Neoplasms / Q000453:epidemiology / Q000235:genetics; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics*; D019683:Penetrance; D012042:Registries / Q000706:statistics & numerical data; D012306:Risk
D051856:Fanconi Anemia Complementation Group Proteins